Realcan Pharmaceutical Group Co., Ltd. (SHE:002589)
China flag China · Delayed Price · Currency is CNY
3.270
-0.020 (-0.61%)
At close: Feb 13, 2026

SHE:002589 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Cash & Equivalents
4,2414,9845,0615,3404,5795,753
Trading Asset Securities
-----40.79
Cash & Short-Term Investments
4,2414,9845,0615,3404,5795,794
Cash Growth
-9.53%-1.52%-5.23%16.63%-20.97%13.77%
Accounts Receivable
4,3834,3754,2224,60311,27615,183
Other Receivables
944.69892.75990.011,6701,8971,429
Receivables
5,3285,2685,2126,27413,17216,611
Inventory
692.93734.741,119954.512,0682,938
Prepaid Expenses
-00.11-7.270.9
Other Current Assets
181.0394.88147.07250.97845.881,217
Total Current Assets
10,44311,08111,53912,82020,67226,561
Property, Plant & Equipment
2,0372,2382,2772,2972,5273,189
Long-Term Investments
743.31746.72852.03594.07805.82777.68
Goodwill
146.67146.67146.67146.69620.27804.51
Other Intangible Assets
519.55440.89552.39624.21478.35319.63
Long-Term Accounts Receivable
----0.070.87
Long-Term Deferred Tax Assets
303.52286.15284.44106.68122.8692.43
Long-Term Deferred Charges
51.8839.1660.8789.93134.58148.71
Other Long-Term Assets
1,0841,033996.391,6541,035243.91
Total Assets
15,32916,01216,70918,33226,39732,137
Accounts Payable
3,4623,3823,7237,7159,7918,274
Accrued Expenses
18.0742.2166.9857.68227.5472.3
Short-Term Debt
5,3766,0926,5563,9264,44010,055
Current Portion of Long-Term Debt
27.53155.385.66.516.3-
Current Portion of Leases
-0.760.521.8210.091.2
Current Income Taxes Payable
29.423.621.68591.82154.62
Current Unearned Revenue
12.4225.1329.1232.43174.72233.92
Other Current Liabilities
472.66232.26378.53724.461,7661,977
Total Current Liabilities
9,3989,93310,76112,46816,50821,168
Long-Term Debt
425.4327.08261.2767.248.58.36
Long-Term Leases
2.614.120.842.7339.19-
Long-Term Unearned Revenue
4.714.741.621.9317.518.88
Long-Term Deferred Tax Liabilities
44.0248.547.4840.5883.56181.34
Other Long-Term Liabilities
----7.28245.62
Total Liabilities
9,87510,31811,07212,58116,70421,622
Common Stock
1,5051,5051,5051,5051,5051,505
Additional Paid-In Capital
3,4833,5893,7203,7014,0154,020
Retained Earnings
421.58444.35453.83432.662,2782,175
Treasury Stock
-60.39--230.65-230.65-230.65-230.65
Total Common Equity
5,3495,5385,4485,4077,5677,469
Minority Interest
105.21156.83189.183442,1263,046
Shareholders' Equity
5,4545,6955,6375,7519,69310,515
Total Liabilities & Equity
15,32916,01216,70918,33226,39732,137
Total Debt
5,8316,5796,8244,0044,54410,064
Net Cash (Debt)
-1,590-1,595-1,7641,33634.82-4,271
Net Cash Growth
---3737.34%--
Net Cash Per Share
-1.06-1.06-1.170.900.02-2.94
Filing Date Shares Outstanding
1,4841,5051,4961,4961,4961,496
Total Common Shares Outstanding
1,4841,5051,4961,4961,4961,496
Working Capital
1,0451,148777.98351.124,1645,393
Book Value Per Share
3.603.683.643.615.064.99
Tangible Book Value
4,6834,9504,7494,6366,4686,345
Tangible Book Value Per Share
3.153.293.173.104.324.24
Buildings
-1,9741,8191,8651,4681,695
Machinery
-686.13695.38778.651,4361,530
Construction In Progress
-307.34429.34315.37549.58870.89
Source: S&P Global Market Intelligence. Standard template. Financial Sources.